{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:55:20Z","timestamp":1790286920475,"version":"4.1.0"},"reference-count":50,"publisher":"Wiley","issue":"S6","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Drug\u2010induced photosensitivity is associated with a wide range of anticancer treatments, including conventional chemotherapeutic agents, targeted anticancer therapies, and immune checkpoint inhibitors. These dermatologic adverse events can have a major impact on the well\u2010being and quality of life of cancer patients, leading to dose modifications and interruption or discontinuation of anticancer treatments in severe cases. However, the heterogeneous nature of the photosensitive reactions induced by these agents, as well as the common concomitant use of other potentially photosensitizing drugs (antibiotics, voriconazole, nonsteroidal anti\u2010inflammatory drugs, etc.), can make the diagnosis and, therefore the prevention, of these adverse events particularly challenging. The aim of this review is to describe the most characteristic forms of photosensitivity observed in patients being treated with anticancer treatments, including phototoxicity and photoallergy, and other potentially photo\u2010induced manifestations such as UV recall, exaggerated sunburn reactions associated with treatment\u2010related vitiligo, drug\u2010induced cutaneous lupus erythematosus, and UV\u2010induced hyperpigmentation. We also discuss the photosensitive reactions recently reported with new\u2010generation targeted anticancer therapies and immune checkpoint inhibitors and highlight the importance of continued surveillance to identify photosensitizing agents, and of educating patients on the need for preventive UVA\/UVB photoprotective measures.<\/jats:p>","DOI":"10.1111\/jdv.18200","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T21:07:30Z","timestamp":1656018450000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Anticancer treatments and photosensitivity"],"prefix":"10.1111","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2585-6633","authenticated-orcid":false,"given":"V.","family":"Sibaud","sequence":"first","affiliation":[{"name":"Oncodermatology Department, Claudius REGAUD Institute and Cancer University Institute Toulouse Oncopole  Toulouse Cedex 9 France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)91271-1"},{"key":"e_1_2_10_3_1","volume-title":"Photosensitivity. StatPearls [internet]","author":"Oakley AM","year":"2020"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-019-00806-5"},{"key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ddg.14314","article-title":"Drug\u2010induced photosensitivity: culprit drugs, potential mechanisms and clinical consequences","volume":"19","author":"Hofmann GA","year":"2021","journal-title":"J Dtsch Dermatol Ges"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12533"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2012.12.012"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.01.077"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70488-3"},{"key":"e_1_2_10_10_1","first-page":"203 e201","article-title":"Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. conventional chemotherapeutic drugs","volume":"71","author":"Reyes\u2010Habito CM","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2020.06.007"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.01.884"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2006.02245.x"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.06.061"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3791"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1980.tb01993.x"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.11.009"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2016.2833"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06733.x"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2012.00669.x"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000071795"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0333"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/2013.jamadermatol.192"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14797"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15818"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30061-9"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-020-01035-9"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.06.044"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.2734"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11812"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020482"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt015"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1113752"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.2.239"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000452425"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.05.003"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.177"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15214"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.10110.x"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13018"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2016.2912"},{"key":"e_1_2_10_42_1","first-page":"e7828","article-title":"Discoid lupus erythematosus lesions associated with systemic fluorouracil agents: a case report and review","volume":"12","author":"Cohen PR","year":"2020","journal-title":"Cureus"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14716"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-021-01071-1"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001120"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000536"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0336-3"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3681"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.03.132"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.005"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2016.05.006"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.18200","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.18200","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.18200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T21:11:29Z","timestamp":1692825089000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.18200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":50,"journal-issue":{"issue":"S6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1111\/jdv.18200"],"URL":"https:\/\/doi.org\/10.1111\/jdv.18200","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"2021-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}